Pfizer/BioNTech COVID-19 Vaccine Wins EU Green Light
Executive Summary
The first COVID-19 vaccine will shortly be available to the EU member states. The European Medicines Agency says that uncertainties remain over the ability of the vaccine to prevent transmission of the coronavirus and whether the new variant strain will render this and other vaccines less effective.
You may also be interested in...
Pfizer’s Amplyx Buy Continues Infectious Disease Deal-Making Spree
Pfizer will develop the novel antifungal fosmanogepix. The big pharma has made several other recent anti-infective deals, including when it expanded its BioNTech vaccine alliance to include COVID-19.
Argentina Follows UK In Backing Oxford/AstraZeneca COVID-19 Vaccine
While the US and EU regulators seem less than keen on the data package offered to date on COVID-19 Vaccine AstraZeneca, Latin American countries are moving quickly to follow the UK in backing the cost-effective and more-easily deliverable option.
After UK OK, Argentina Backs AstraZeneca/Oxford COVID-19 Vaccine
While the US and EU regulators seem less than keen on the data package offered to date on COVID-19 Vaccine AstraZeneca, Latin American countries are moving quickly to follow the UK in backing the cost-effective option.